Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.1002/hon.2897
dc.identifier.other
WOS:000668225700001
dc.description.volume
dc.description.issue
Publisher
WILEY
DOI
10.1002/hon.2897